The tent comes in a rainbow of colors and three sizes. Stakes, ropes, sandbags, and a wheeled carrying case that doubles as a ...

Guselkumab was associated with significant inhibition of structural joint damage in adults with active psoriatic arthritis. The Food and Drug Administration (FDA) has approved updated labeling for ...

Johnson & Johnson (JNJ) has received FDA approval to expand the label for its monoclonal antibody therapy Tremfya to prevent further joint damage in psoriatic arthritis, an immune-mediated condition ...

What Is Tremfya, and Why Does It Matter? Tremfya is a prescription biologic medicine used as an intravenous injection or under-the-skin shot for treating certain immune-related inflammatory diseases.

Johnson & Johnson said the FDA has approved its once-daily psoriasis pill Icotyde. Icotyde targets IL-23, rivaling best-selling shots Tremfya and Skyrizi. J&J hasn't announced how much Icotyde will ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Lifestyle brand Skullcandy has announced its new Push 540 Open open-ear true wireless ...

For months now, all signs have pointed to a looming, steep dropoff in pharmas’ spending on traditional TV advertising. One brand that seems not to have gotten the memo, however, is Johnson & Johnson’s ...

The Eagles' version of the quarterback sneak has been less effective this season. Elsa / Getty Images PHILADELPHIA — The Philadelphia Eagles are known for the trademark quarterback sneak play ...

Xoma argued Janssen breached the contract Xoma had with the third-party pharmaceutical company, as well as the contract the company and Janssen had, by failing to obtain a commercial license from Xoma ...

Johnson & Johnson’s Tremfya retained the top spot for TV pharma brand ad impressions in September, as the fall sports season got underway in earnest. The J&J brand achieved an impressions share of ...